China Pharma Holdings (CPHI) Deferred Taxes (2010 - 2018)
China Pharma Holdings (CPHI) posted Deferred Taxes of -$1195.0 for Q4 2018, down 105.68% on a QoQ basis from $21039.0 in Q3 2018, and down 103.91% year-over-year from $30525.0 in Q4 2017.
China Pharma Holdings (CPHI) Deferred Taxes (2010 - 2018) Analysis & Trends
China Pharma Holdings' Deferred Taxes history runs 9 years deep, the most recent figure standing at -$1195.0 for Q4 2018.
- Quarterly Deferred Taxes fell 103.91% year-over-year to -$1195.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $68419.0 (down 44.21% YoY) and the FY2018 annual result came in at $68419.0, down 44.21% from the prior year.
- Deferred Taxes was -$1195.0 for Q4 2018 at China Pharma Holdings, down from $21039.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $421825.0 in Q3 2015 and bottomed at -$1195.0 in Q4 2018.
- A 5-year average of $58385.9 and a median of $21039.0 in 2018 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2015 — Deferred Taxes soared 2095.29% — and 2018, when it plunged 103.91%.
- China Pharma Holdings' Deferred Taxes stood at $19284.0 in 2014, then surged by 2087.44% to $421825.0 in 2015, then tumbled by 42.36% to $243131.0 in 2016, then tumbled by 87.45% to $30525.0 in 2017, then tumbled by 103.91% to -$1195.0 in 2018.
- Business Quant data shows CPHI's Deferred Taxes at -$1195.0 in Q4 2018, $21039.0 in Q3 2018, and $22590.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -1,195.00 |
| Sep 30, 2018 | 21,039.00 |
| Jun 30, 2018 | 22,590.00 |
| Mar 31, 2018 | 25,985.00 |
| Dec 31, 2017 | 30,525.00 |
| Sep 30, 2017 | 31,198.00 |
| Jun 30, 2017 | 30,574.00 |
| Mar 31, 2017 | 30,334.00 |
| Dec 31, 2016 | 243,131.00 |
| Sep 30, 2016 | 20,800.00 |
| Sep 30, 2015 | 421,825.00 |
| Jun 30, 2015 | 19,428.00 |
| Mar 31, 2015 | 19,284.00 |
| Dec 31, 2014 | 19,284.00 |
| Sep 30, 2014 | 19,215.00 |
| Jun 30, 2014 | 19,196.00 |
| Mar 31, 2014 | 19,347.00 |
| Dec 31, 2013 | 2.19 Mn |
| Sep 30, 2013 | -472,512.00 |
| Jun 30, 2013 | -688,755.00 |